Search

Anita K Gandhi

from Bernardsville, NJ
Age ~51
Get Report
Also known as:
Anita R Gandhi, Anita Krithivas, Anita Kirthivas
Phone and address:
37 Stirling Rd, Bernardsville, NJ 07924
(908) 766-1978
Connected to:
Abha Gandhi, 52Adrienne J Gandhi, 44Alisha K Gandhi, 28Alpa D Gandhi, 45Amjad Gandhi, 33Animesh V Gandhi, 31Anisha P Gandhi, 33Ann Gandhi, 45Avi V Gandhi, 31Balaji Gandhi, 47

Anita Gandhi Phones & Addresses

  • 37 Stirling Rd, Bernardsville, NJ 07924 (908) 766-1978
  • Basking Ridge, NJ
  • Burlington, MA
  • Denville, NJ
  • Wallingford, CT
  • Baltimore, MD
  • Uncasville, CT
  • Milford, CT
  • 37 Stirling Rd, Bernardsville, NJ 07924

Specialities

Buyer's Agent • Listing Agent

Professional Records

Medicine Doctors

Anita Gandhi Photo 1

Anita M. Gandhi

View page
Specialties:
Obstetrics & Gynecology
Education:
Medical School
Univ of Western Ontario, Fac of Med, London, Ont, Canada
Graduated: 2005
Procedures:
Cesarean Section (C-Section)
D & C Dilation and Curettage
Delivery After Previous Caesarean Section
Hysterectomy
Myomectomy
Tubal Surgery
Vaccine Administration
Vaginal Delivery
Vaginal Repair
Conditions:
Abnormal Vaginal Bleeding
Candidiasis of Vulva and Vagina
Complicating Pregnancy or Childbirth
Conditions of Pregnancy and Delivery
Endometriosis
Description:
Dr. Gandhi graduated from the Univ of Western Ontario, Fac of Med, London, Ont, Canada in 2005. She works in Aurora, IL and 1 other location and specializes in Obstetrics & Gynecology. Dr. Gandhi is affiliated with Presence Mercy Medical Center and Rush Copley Medical Center.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Anita Gandhi
Associate Scientist
Celgene
Biotechnology · Sales Of Ethical Prescription Pharmaceuticals · Sales of Ethical Prescription Pharmaceuticals · Manufacturing · Chemical Manufacturing · Pharmaceutical and Medicine Manufacturing · Mfg Pharmaceutical Preparations · Pharmaceutical Research & Development
86 Morris Ave, Summit, NJ 07901
86 Morris Avenue  , Summit, NJ 07901
1209 Orange Street  , Wilmington, DE 19801
106 Allen Rd, Basking Ridge, NJ 07920
(908) 673-9000, (858) 558-7500, (952) 975-7000, (952) 975-7012

Publications

Us Patents

Methods And Compositions Using Pde4 Inhibitors For The Treatment And Management Of Autoimmune And Inflammatory Diseases

View page
US Patent:
20120276087, Nov 1, 2012
Filed:
Apr 27, 2012
Appl. No.:
13/458896
Inventors:
Peter H. SCHAFER - Somerset NJ, US
Anita GANDHI - Bernardsville NJ, US
Lori CAPONE - Edison NJ, US
International Classification:
A61K 31/404
A61P 19/02
A61P 29/00
A61K 39/395
A61P 19/06
A61K 38/13
A61K 31/519
A61K 38/16
A61P 17/06
A61P 19/04
US Classification:
4241331, 514417, 514416, 514 167, 514249, 514 168, 4241421, 514 186
Abstract:
Methods of treating, preventing, or managing autoimmune inflammatory diseases and disorders including but not limited to spondylitis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, and rheumatoid arthritis by the administration of phosphodiesterase 4 (PDE4) inhibitors in combination with other therapeutics are disclosed. Pharmaceutical compositions, dosage forms, and kits suitable for use in methods of the invention are also disclosed.

Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor

View page
US Patent:
20120322073, Dec 20, 2012
Filed:
Apr 27, 2012
Appl. No.:
13/459005
Inventors:
Peter H. Schafer - Somerset NJ, US
Anita Gandhi - Bernardsville NJ, US
Derek Mendy - San Diego CA, US
Thomas O. Daniel - La Jolla CA, US
International Classification:
G01N 33/574
G01N 21/75
C12Q 1/68
C07K 16/18
US Classification:
435 612, 5303879, 5303891, 435 71
Abstract:
Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.

Methods Of Treating Cancer Using 3-(4-((4-(Morpholinomethyl)Benzyl)Oxy)-1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione

View page
US Patent:
20140045843, Feb 13, 2014
Filed:
Aug 8, 2013
Appl. No.:
13/962776
Inventors:
Anita Gandhi - Bernardsville NJ, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
A61K 31/5377
A61K 39/395
A61K 45/06
US Classification:
5142352, 4241331
Abstract:
Provided herein are methods of treating, preventing and/or managing cancers, which comprise administering to a patient 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.

Treatment Of Immune-Related And Inflammatory Diseases

View page
US Patent:
20140045844, Feb 13, 2014
Filed:
Aug 8, 2013
Appl. No.:
13/962786
Inventors:
Rajesh Chopra - Summit NJ, US
Anita Gandhi - Bernardsville NJ, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
C07D 413/14
US Classification:
5142352
Abstract:
Provided herein are methods of using compounds and compositions for modulating leukocytic activity, including activity of B cells and/or T cells monocytes, macrophages, and other lymphoid or myeloid-derived cell types, in immune-related diseases or inflammatory diseases. Pharmaceutical compositions and dosing regimens for use in the methods are also provided herein.

Methods Of Treating Cancer Using 3-(5-Amino-2-Methyl-4-Oxo-4H-Quinazolin-3-Yl)-Piperidine-2,6-Dione

View page
US Patent:
20120230983, Sep 13, 2012
Filed:
Mar 9, 2012
Appl. No.:
13/417088
Inventors:
George W. Muller - Rancho Santa Fe CA, US
Peter H. Schafer - Somerset NJ, US
Hon-Wah Man - Princeton NJ, US
Ling-Hua Zhang - Mountain Lakes NJ, US
Anita Gandhi - Bernardsville NJ, US
Rajesh Chopra - Summit NJ, US
International Classification:
A61K 31/517
A61K 31/56
C12Q 1/68
A61K 39/395
G01N 33/574
A61P 35/04
A61K 31/704
US Classification:
4241331, 51426622, 514171, 514 34, 435 792, 435 612
Abstract:
Provided herein are methods of treating, preventing and/or managing cancers, which comprise administering to a patient 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.

Treatment Of Immune-Related And Inflammatory Diseases

View page
US Patent:
20210340132, Nov 4, 2021
Filed:
Nov 23, 2020
Appl. No.:
17/102237
Inventors:
- Summit NJ, US
Rajesh Chopra - Sutton, GB
Anita Gandhi - Bernardsville NJ, US
International Classification:
C07D 413/14
A61K 31/5377
Abstract:
Provided herein are methods of using compounds and compositions for modulating leukocytic activity, including activity of B cells and/or T cells monocytes, macrophages, and other lymphoid or myeloid-derived cell types, in immune-related diseases or inflammatory diseases. Pharmaceutical compositions and dosing regimens for use in the methods are also provided herein.

Treatment Of Immune-Related And Inflammatory Diseases

View page
US Patent:
20210122727, Apr 29, 2021
Filed:
Sep 2, 2020
Appl. No.:
17/010699
Inventors:
- Summit NJ, US
Ying Ye - Branchburg NJ, US
Donna J. Sutherland - Green Brook NJ, US
Rajesh Chopra - Sutton, GB
Anita Gandhi - Bernardsville NJ, US
International Classification:
C07D 401/04
A61K 31/5377
A61K 45/06
Abstract:
Provided herein are methods of using compounds and compositions for modulating leukocytic activity, including activity of B cells and/or T cells monocytes, macrophages, and other lymphoid or myeloid-derived cell types, in immune-related diseases or inflammatory diseases. Pharmaceutical compositions and dosing regimens for use in the methods are also provided herein.

Methods For Treating Diffuse Large B-Cell Lymphoma And The Use Of Biomarkers As A Predictor To Responsiveness To Drugs

View page
US Patent:
20210102257, Apr 8, 2021
Filed:
May 18, 2020
Appl. No.:
16/877429
Inventors:
- Summit NJ, US
Alberto Risueno Perez - Sevilla, ES
Michael Pourdehnad - San Francisco CA, US
Anita Gandhi - Bernardsville NJ, US
Patrick Hagner - Sparta NJ, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
C12Q 1/6886
Abstract:
In one aspect, provided herein are methods for predicting the responsiveness of DLBCL patients to treatment with lenolidomide or Compound A; or a stereoisomer thereof; or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate thereof; or a polymorph thereof utilizing biomarkers or classfiers that correlate with responsiveness to one of these drugs. In another aspect, provided herein are methods for treating a DLBCL patient determined to be responsive to treatment with lenolidomide or Compound A; or a stereoisomer thereof; or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate thereof; or a polymorph thereof utilizing biomarkers or classifiers (or output thereof) that correlate with responsiveness to one of these drugs.
Control profile
Anita K Gandhi from Bernardsville, NJ, age ~51 Get Report